This document discusses cytology and histopathology techniques for diagnosing diseases. It covers when cytology should be used, such as for pre-surgical diagnosis or staging. It describes how to perform cytology by ensuring the sample is of the intended lesion and of diagnostic quality. The document discusses interpreting cytology samples to determine if they show inflammation, necrosis, or a neoplastic process. For difficult cases like lymphoma, it recommends additional tests like immunophenotyping, PARR, and flow cytometry. The document also discusses when histopathology is important, such as for determining surgical margins, and when immunohistochemistry may be needed to reach a diagnosis.
Primary GIT lymphoma typically refers to a lymphoma that predominantly involves any section of the GIT from the oropharynx to the rectum. The GIT is the predominant site of extra nodal lymphoma involvement, mostly are non-Hodgkin lymphomas (NHLs).
A brief description on Cholangiocarcinoma, its classification and management. Contains management of Intrahepatic cholangiocarcinoma, Perihilar cholangiocarcinoma, Distal cholangiocarcinoma.
Cholangiocarcinomas (bile duct cancers) arise from the epithelial cells of the intrahepatic and extrahepatic bile ducts.
Please do not edit or rename.
Note it is only for academic purposes.
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
Primary GIT lymphoma typically refers to a lymphoma that predominantly involves any section of the GIT from the oropharynx to the rectum. The GIT is the predominant site of extra nodal lymphoma involvement, mostly are non-Hodgkin lymphomas (NHLs).
A brief description on Cholangiocarcinoma, its classification and management. Contains management of Intrahepatic cholangiocarcinoma, Perihilar cholangiocarcinoma, Distal cholangiocarcinoma.
Cholangiocarcinomas (bile duct cancers) arise from the epithelial cells of the intrahepatic and extrahepatic bile ducts.
Please do not edit or rename.
Note it is only for academic purposes.
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
A presentation by Dr Dave Collins of SASH Vets Sydney
on Canine Biliary Disease - Gallbladder mucocoeles, Cholangitis and Extrahepatic bile duct obstruction.
SASH : Intravenous Lipid Emulsion - Applications in Toxicology by Dr Nicole ...SASH Vets
A presentation by Dr Nicole Spurlock
Emergency and Critical Care Medicine Vet at SASH veterinary hospital in Sydney Australia on Intravenous Lipid Emulsion and its Applications in Toxicology
A short presentation on the diagnostic procedure involved in Leukemia identification and possible treatment available currently. This presentation includes the types of leukemia, risk factors, symptoms, treatment methods, and advanced techniques.
Liquid Biopsy Overview, Challenges and New Solutions: Liquid Biopsy Series Pa...QIAGEN
A liquid biopsy is often described as a sensitive and specific blood test to detect circulating tumor cells (CTCs). CTCs, shed by both the primary and metastasized tumors, carry specific information about their origins and markers that will enable us to discover new diagnosis, prognosis and therapeutic targets. This slidedeck gives an overview of the recent progress in exploring the predictive potential of circulating biomarkers, including circulating tumor cells, circulating tumor DNA, microRNAs, long non-coding RNAs (lncRNAs) and exosomes. Addressing both biological and technical aspects, we detail the isolation and characterization of circulating biomarkers. Challenges and solutions are also featured.
Fluid cytology in serous cavity effusionstashagarwal
The intrathoracic and intraperitoneal organs are covered by a single layer of mesothelial cells, which is continuous with the lining of the thoracic and peritoneal cavities. The potential space between the two layers of epithelium contains a small amount of lubricating fluid.
Serous fluid lies between the membranes lining the body cavities(parietal) and those covering the organs within the cavities(visceral).
Production and reabsorption are normally at a constant rate. They are influenced by
Changes in osmotic and hydrostatic pressure in the blood.
Concentration of chemical constituents in the plasma
Permeability of blood vessels and membranes.
An accumulation of fluid, called an effusion, results from an imbalance of fluid production and reabsorption. This fluid accumulation in the pleural, pericardial, and peritoneal cavities is known as serous effusion.
Investigations for iufd & sb, how to select?Wafaa Benjamin
Foetal loss is a distressing situation for the lady ,family and medical staff as well.
Investigating the cause of death has many benefits .
Meticulous history taking and clinical assessment is of at most importance.
There are routine standard tests & others arte selective directed by clinical scenarios.
Researches & recording are required to estimate main causes of foetal death at local level, so, investigations could be directed.
In presence of lack of resources, selection of investigations should be prioritized by most relevant and most informative ones.
Post-mortem examination should be re-included at least external examination & placental histopathology.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. Nailing the diagnosis
Help your pathology help you
• Cytology
• When, how, what and where?
• Advanced cytology and additional tests
• Histopathology
• Pre-op, post-op- when does it matter?
• When do we ask for immunohistochemistry?
5. CYTOLOGY:
WHEN
Pre-surgical diagnosis is encouraged
• Owners expectations: prognosis and financial considerations
• Determine whether further information is required prior definitive
surgery
• Staging
• May result in non-surgical treatment as best option
• Not considered a substitute for histopathology
7. CYTOLOGY
HOW
• Make sure what you are sampling is what you wish to sample
• Make sure what you have sampled is of diagnostic quality
• repeat multiple times if necessary, use different techniques
• Make sure that you submit an adequate number of slides
8. CYTOLOGY
HOW
fat
lesion
• Make sure what you are
sampling is what you
wish to sample
• ‘Hugo’ is a 12 y MN Rottweiler X
• Presented August 2014 for oncological
and surgical assessment of an infiltrating
lipoma
• Fine needle aspirates by referring vet had
consistently revealed droplets of free fat
and adipocytes
• CT performed to evaluate pre-operatively
9. CYTOLOGY
HOW:
Make sure what you are sampling is what you wish to sample
• Visualisation is the key
• Superficial lesions: estimate trajectory
• Deep lesions: consider imaging as guidance
10. CYTOLOGY:
HOW
Make sure what you have sampled is of diagnostic quality
9y FN Irish Setter
Presented with mammary masses
Vulval mass detected during prep
Fine needle aspirate (FNA)
11. CYTOLOGY:
HOW : MAKE SURE WHAT YOU HAVE SAMPLED IS OF DIAGNOSTIC QUALITY
• Equipment needed
• Common problems encountered with slide preparation:
• Blood contamination
• Low cellularity
• Cell rupture or lysis
• Smear too thick
• Artefacts
12. CYTOLOGY:
HOW : MAKE SURE WHAT YOU HAVE SAMPLED IS OF DIAGNOSTIC QUALITY
• Common problems encountered with slide preparation:
• Blood contamination
• Low cellularity
• Cell rupture or lysis
• Smear too thick
• Artefacts
-Lymph nodes
-Mast cell tumours
-Internal organs
Liver, spleen
-Vascular tumours
-Ulcerated lesions
-Mucous membranes
Spindle cell tumours
Easy to exfoliate:
Round cell tumours
+/- epithelial cells
13. CYTOLOGY:
HOW : MAKE SURE WHAT YOU HAVE SAMPLED IS OF DIAGNOSTIC QUALITY
• Common problems encountered with slide preparation:
• Blood contamination
• Low cellularity
• Cell rupture or lysis
• Smear too thick
• Artefact
14. CYTOLOGY:
HOW : MAKE SURE WHAT YOU HAVE SAMPLED IS OF DIAGNOSTIC QUALITY
1. Is the slide of diagnostic quality?
2. Are there different types of cells present?
3. Are inflammatory cells present?
4. Can you identify the cells belonging to the tissue of origin?
5. Unusual cells?
a. Shape
b. Cluster or occur individually
c. Cytoplasmic detail and nuclear detail
6. Extra cellular material/infectious agents
15. CYTOLOGY:
WHAT IS IT?
Is the slide of
diagnostic quality?
Yes
Are there different
types of cells
present?
Yes
Are inflammatory cells
present?
Yes
Can you identify the
cells belonging to
the tissue of origin?
Yes, epithelial cells
Unusual cells? No
Extra cellular
material/infectious
agents
No
16. CYTOLOGY:
WHAT IS IT?
Is the slide of
diagnostic quality?
Yes
Are there different
types of cells
present?
Yes
Are inflammatory
cells present?
Yes
Can you identify the
cells belonging to
the tissue of
origin?
Yes, epithelial
cells
Unusual cells? No
Extra cellular
material/infectious
agents
No
Inflammatory
Neoplastic
Degenerative
18. CYTOLOGY:
WHAT IS IT?
Neoplastic
• Cytological criteria of malignancy:
• Nuclear criteria
• e.g.: variation in nuclear size and shape- multinucleation, especially if nuclei within same cell vary in size;
increased nuclear:cytoplasmic ratio or variation within same population of cells; coarse and ropey chromatin
pattern; nuclear moulding; increased number of mitotic figures; variation in nucleolar size, shape and
number, especially within same nucleus- bizarre forms,
• Cellular criteria
• e.g. variation in cell size and shape (greater in malignancy), cell population in abnormal location
• Cytoplasmic criteria
• e.g. cytoplasmic basophilia, vacuolation and granulation
20. CYTOLOGY:
WHAT IS IT?
Is the slide of
diagnostic quality?
Yes
Are there different
types of cells
present?
Yes
Are inflammatory
cells present?
Yes
Can you identify the
cells belonging to
the tissue of
origin?
Yes, epithelial
cells
Unusual cells? No
Extra cellular
material/infectious
agents
No
Inflammatory
21. CYTOLOGY:
WHAT IS IT?
• Limitations
• Mammary > histopathology
• Cannot grade
• May not be definitive
22. CYTOLOGY: WHERE?
WHERE CAN WE SAMPLE, WHERE SHOULD WE SAMPLE?
• External tissues
• Internal tissues and fluid
• Contra-indications include:
Vascular lesion
Coagulopathy
Impaired access
Hollow organ
Cancer seeding (TCC)
23. CYTOLOGY: WHERE?
WHERE CAN WE SAMPLE, WHERE SHOULD WE SAMPLE?
• Staging
• Performed on patients with malignant lesions
• Knowing pattern of metastatic spread is helpful
• Less differentiated MCT recommend lymph node, liver and spleen aspirates
• Soft tissue sarcoma: haematogenous route to lungs (other soft tissue, liver) common
• Subtype dependent: histiocytic/synovial cell sarcoma to regional LN (plus lung, etc)
• Carcinoma: lymphatic route
24. CYTOLOGY: WHERE CAN WE SAMPLE, WHERE SHOULD WE SAMPLE?
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
• Multi-centric lymphoma
• Which lymph nodes?
• How many samples?
• What should I be requesting to maximise my diagnosis?
25. • Immunocytochemistry and immunohistochemistry refer to
the process of detecting antigens in tissues or cells by
exploiting the antigen-antibody binding process found in
biological tissues.
CYTOLOGY:
LYMPHOMA- SPECIAL CONSIDERATIONS
IMMUNOPHENOTYPING AND FLOW CYTOMETRY
26. IMMUNOPHENOTYPING
• The diversity of immunophenotyping markers used in
diagnostic pathology is substantial and more markers are
becoming available in the veterinary field. Some examples of
commonly used markers include:
– CD3: T cell lymphoma
– CD79a: B cell lymphoma
– CD18, 11: Histiocytic disease
– CD117: KIT used to identify MCT’s and GIST’s
– Vimentin: a marker common to sarcomas
27. PARR AND FLOW
What is the difference between flow cytometry and PARR?
• The PARR assay is a PCR assay in which we are amplifying DNA to evaluate lymphocyte
(LCT) receptor gene length. In a heterogenous LCT population the LCT’s are all genetically
distinct so the LCT receptor genes vary in length.
• Homogenous or clonal LCT population, is often malignant and have identical gene length
throughout the population.
• The results tell us if the majority of cells in the sample
are derived from the same original clone (most
consistent with neoplasia), or from multiple clones
(most consistent with a reactive process- inflammation,
immune mediated disease or infection)
28. PARR AND FLOW
What is the difference between flow cytometry and PARR?
• Flow cytometry (FC) allows identification and quantitation of cell surface
markers
• The FC study involves staining live cells (blood, BM, LCT) with labelled
antibodies that bind to proteins expressed on the cell surface
• The cells are analyzed on a flow cytometer, which tells us how many cells of each type are
present. This information allows us to determine the lineage of the cells present, and
whether they are homogeneous (more consistent with neoplasia) or heterogeneous (more
consistent with a reactive process
• Limitation – sample collection- appropriate cytofixative for FNA samples (48 hours), or
blood/bone marrow into EDTA (24 hours)
29. CYTOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
FLOW CYTOMETRY
• Immunophenotyping lymphoma
• Prognosis
• Treatment guidance
CD3 (T cell marker)
CD4 (helper T cells)
CD5 (T cell marker)
CD8 (cytotoxic T cells)
CD21 (B cells, but not their precursors)
CD34 (stem cell marker, expressed in acute
leukaemia)
CD3-e (pan T cell marker)
CD79a (pan B cell marker)
Myeloperoxidase (expressed by myeloblasts
and granulocyte precursors)
MAC387 (expressed by monoblasts, and
some granulocyte precursors)
CD14 (expressed by monoblasts and
monocytes)
30. CYTOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
FLOW CYTOMETRY
• Differentiation of hyperplasia and neoplastic populations
• Characterisation of leukaemias CD3 (T cell marker)
CD4 (helper T cells)
CD5 (T cell marker)
CD8 (cytotoxic T cells)
CD21 (B cells, but not their precursors)
CD34 (stem cell marker, expressed in acute
leukaemia)
CD3-e (pan T cell marker)
CD79a (pan B cell marker)
Myeloperoxidase (expressed by myeloblasts
and granulocyte precursors)
MAC387 (expressed by monoblasts, and
some granulocyte precursors)
CD14 (expressed by monoblasts and
monocytes)
31. CYTOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
PARR
• Sample factors:
• cell lysis/poor preservation
• low diagnostic yield
• location of sample- e.g. intestinal tract
• Disease factors:
• equivocal diagnosis- ‘reactive node’
• early diagnosis
• certain lymphoma sub-types versus
• persistent lymphocytosis
34. HISTOPATHOLOGY
Pre-op, post-op- when does it matter?
• Pre-operative histopathology especially important when
grading may influence surgical plan
• Surgical margins
Grade 1 and 2:
Minimum 2 cm and one deep
fascial plane
Grade 3:
Minimum 3 cm and one deep
fascial plane
Mast cell tumour, H+E
35. HISTOPATHOLOGY
Pre-op, post-op- when does it matter?
• Pre-operative histopathology especially important when
grading may influence surgical plan
• Surgical approach when surgery may be challenging:
• large
• localisation
36. HISTOPATHOLOGY
Pre-op, post-op- when does it matter?
• Pre-operative histopathology is not indicated where there
is no influence on surgical plan
• Location
• renal
• spleen
• mammary
Always obtain
post-operative
histopathology
37. HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
• Diagnosis is inconclusive
• Diagnosis does not fit clinical picture
• Where a more precise diagnosis will influence
prognosis or treatment
•Round cell neoplasia
•Fibrohistiocytic splenic neoplasia
•Intestinal neoplasia (sarcoma, other)
38. HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
•‘Forster’, 12y MN Border Collie
•Presented as a referral for a recurrent oral
melanoma
Forster’s biopsy:
Round cell
population
39. • Further diagnosis with
histopathology and
immunohistochemistry
Epitheliotropic T cell lymphoma
Amelanotic melanoma
Round cells
Histiocytic cells
Mast cells
Lymphoma
Plasma cells
TVT
(Melanoma)
HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
40. Lip mass. Extensively infiltrating through the submucosa are myriad
round cells with scant amounts of lightly eosinophilic to clear
cytoplasm and no obvious pigment. The cells have atypical lymphoid
appearance with round nuclei containing granular to branched chromatin
and 1 nucleolus. Some of the nuclei are indented while occasional cells
have a slightly larger nucleus. The cells show aggregation around
vessels as well as infiltration into bundles of nerve and skeletal
muscle. The mitotic index is 5. There are scattered interstitial
eosinophils, small dark lymphocytes, occasional plasma cells and
macrophages. Within the overlying haired skin is a similar population of
round cells showing epitheliotropism, and also affecting hair follicles,
sebaceous glands and sweat glands. These cells often have clear
cytoplasm and infiltrate epithelium as individual cells and small
clusters. Affected regions of the epithelium are subtended by plasma
cells, small dark lymphocytes and a few of the atypical lymphocytes.
Distribution of this change within the affected haired skin is not
uniform. The mucosal surface is affected but to a lesser extent.
Neoplastic cells are not seen at mucosal and haired skin margins.
IMMUNOHISTOCHEMISTRY REPORT
The neoplastic lymphocytes within epithelium and deeper tissue are
strongly and uniformly labelled with CD3
Lip mass. Extensively infiltrating through the submucosa are myriad
round cells with scant amounts of lightly eosinophilic to clear
cytoplasm and no obvious pigment. The cells have atypical lymphoid
appearance with round nuclei containing granular to branched chromatin
and 1 nucleolus. Some of the nuclei are indented while occasional cells
have a slightly larger nucleus. The cells show aggregation around
vessels as well as infiltration into bundles of nerve and skeletal
muscle. The mitotic index is 5. There are scattered interstitial
eosinophils, small dark lymphocytes, occasional plasma cells and
macrophages. Within the overlying haired skin is a similar population of
round cells showing epitheliotropism, and also affecting hair follicles,
sebaceous glands and sweat glands. These cells often have clear
cytoplasm and infiltrate epithelium as individual cells and small
clusters. Affected regions of the epithelium are subtended by plasma
cells, small dark lymphocytes and a few of the atypical lymphocytes.
Distribution of this change within the affected haired skin is not
uniform. The mucosal surface is affected but to a lesser extent.
Neoplastic cells are not seen at mucosal and haired skin margins.
IMMUNOHISTOCHEMISTRY REPORT
The neoplastic lymphocytes within epithelium and deeper tissue are
strongly and uniformly labelled with CD3
• IMHC: CD3 +(CD8+)
HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
Epitheliotropic
lymphoma
41. • Histopathology
• 50% (7/14) of oral cases were conclusively diagnosed
with histopathology alone (Nemec et al, 2012)
• early stages can have marked mixed inflammatory
infiltrate, late stages > B lymphocytes
• >50% there is a mix of lymphocyte cell size reported
• IMHC
• humans: 5-10% lymphoid neoplasia cannot be
diagnosed with use of histopathology and IMHC
• PARR
• T cell receptor (TCR) gamma rearrangement
• Sensitivity 80-95%, Specificity 96-100%
Clinical features
Histopathology
Immunohistochemistry
Clonality testing
Clinical follow up and
repeat biopsy
HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
Epitheliotropic lymphoma: diagnosis
42. HISTOPATHOLOGY:
When do we ask for immunohistochemistry? Diagnosis
Change in diagnosis
Change in management
Surgical > Medical
43. HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
•‘Dudley’, 12y MN Staffordshire Bull Terrier
•Presented as a referral for haemabdomen
•Diagnosed with splenic mass
•Splenectomy after staging
•Diagnosis: splenic sarcoma
The splenic masses reflect
a malignancy which
consists of variably
pleomorphic spindloid to
histiocytic cells admixed
with lymphoid nodules and
extramedullary
haematopoiesis, consisting
with a fibrohistiocytic
nodule.
The regions of necrosis and
areas with a relatively high
mitotic rate warrants a
diagnosis of malignancy.
Diagnosis: splenic sarcoma
44. HISTOPATHOLOGY:
When do we ask for immunohistochemistry?
•Immunohistochemistry requested
•Diagnosis: fibrohistiocytic sarcoma
Vimentin
Desmin
Smooth muscle actin
Factor VIII
CD3
CD79a
CD18
45. • Histologic and immunohistochemical review of splenic fibrohistiocytic nodules (SFHN) in dogs (Moore
2012)
• Splenic FHN cases were re-evaluated in 32 dogs
• Histopathology Grade I(2) Grade II (9) Grade III(21) dogs
• CD3, CD20, CD79a, CD18, CD11d, K1-67 used to reclassify
• Grade I- MZL and lymphoid nodular hyperplasia
• Grade II-MZ hyperplasia(1), MZL (1), complex hyperplasia (2), LNH(1), stromal sarcoma (3)
• Grade III- MZH(1), diffuse large B cell LSA(1), MZL(1)CNH (6),LNH (1), SS (5), HS (6)
• Prognosis:
HISTOPATHOLOGY:
When do we ask for immunohistochemistry? Prognosis
HS- poor 74 days
Stromal sarcoma 488 days, 56% alive 1 year
CNH MST 387 days 70% alive 1 year
LNH MST 570 days 60% alive 2 years
46. HISTOPATHOLOGY:
When do we ask for immunohistochemistry? Therapy
• Intestinal tumours
• Reclassification of small intestinal and cecal smooth
muscle tumours in 72 dogs (Maas et al, 2007)
• Retrospective study of 47 dogs with a prior diagnosis of
leiomyoma or leiomyosarcoma
• 85% reclassified as gastrointestinal stromal tumour
(GIST) or GIST-like
• Therapeutic relevance
• GIST + c-kit, target for tyrosine kinase inhibitors (TKIs)
• Diagnosis is inconclusive
• Diagnosis does not fit clinical picture
• Where a more precise diagnosis will influence prognosis ortreatment
•Round cell neoplasia
•Fibrohistiocytic splenic neoplasia
•Intestinal neoplasia (sarcoma, other)
47. HISTOPATHOLOGY:
When do we ask for immunohistochemistry? Therapy
• Mast cell tumours
• Ki-67 prognostic, may elect adjunctive treatments if high
• KIT (CD 117) if use of TKIs considered
C-Kit staininghigh Ki-67low Ki-67
48. HISTOPATHOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
• Summary of Canine Malignant Lymphoma Revised From the Revised European-American Classification of
Lymphoid Neoplasms/ World Health Organization Classification of Lymphoid Neoplasms
B Cell Neoplasms
Precursor B cell neoplasms
Precursor B lymphoblastic leukemia/lymphoma
Mature (peripheral) B cell neoplasms
B cell chronic lymphocytic leukemia/prolymphocytic
Leukemia/small lymphocytic lymphoma
B cell prolymphocytic leukemia
Lymphoplasmacytic lymphoma
Splenic marginal zone B cell lymphoma
Plasma cell myeloma/plasmacytoma
Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type
Nodal marginal zone lymphoma
Follicular lymphoma
Mantle cell lymphoma
Diffuse large B cell lymphomaa
Mediastinal large B cell lymphoma
Burkitt’s lymphoma/Burkitt’s cell leukemia
Provisional entity: high-grade B cell lymphoma
Burkitt’s-likea
Primary effusion lymphoma
T Cell and Putative Natural Killer Cell Neoplasms
Precursor T cell neoplasm
Precursor T lymphoblastic
Lymphoma/leukemia
Mature (peripheral) T cell and natural killer cell neoplasms
T cell prolymphocytic leukemia
Large granular lymphocyte leukemia (LGL)
Aggressive natural killer (NK) cell leukemia
Peripheral T cell lymphomas, unspecifieda
Adult T cell lymphoma/leukemia
Intestinal T cell lymphoma (+enteropathy associated)
Hepatosplenic gdT cell lymphoma
Subcutaneous panniculitis-like T cell lymphoma
Mycosis fungoides/Sezary syndrome
Anaplastic large cell lymphoma, T and null cell primary cutaneous
type
Peripheral T cell lymphoma not otherwise specified
Angioimmunoblastic T cell lymphoma
Angiocentric T cell lymphoma
a Peripheral T cell lymphomas are those that are not otherwise specified
(NOS) to a specific subtype by further definition
Personalised
lymphoma
treatment
49. • Lymphomas divided into 3 major groups
• high, intermediate, low grade
• Most common lymphoma was centroblastic large B cell
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
(Valli et al, 2010)
50. HISTOPATHOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
(Valli et al, 2010)
Personalised
lymphoma
treatment
• Does the specific diagnosis of lymphoma subtype have a similar impact on survival time in
dogs as it did in humans?
Low grade T cell (T zone)
lymphoma
Longest survival time
(622 days)
T cell high grade
(peripheral T cell)
lymphoma
Shortest survival time
(162 days)
Clinical signs
Low grade often none
High grade frequently
unwell
51. HISTOPATHOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
(Valli et al, 2010)
Personalised
lymphoma
treatment
• Does a specific diagnosis in a dog influence the chemotherapy required?
High Grade B and T cell
lymphoma
Effective chemotherapy
increased survival time
T zone lymphoma
Chemotherapy decreased
survival time
(13 dogs with no
treatment had longest
survival of 687 days)
52. • Indolent lymphoma comprises 5- 29% of all canine lymphomas
• Limited information regarding the subtypes and biological behavior.
• Canine indolent lymphoma consists of a group of diseases that are histopathologically
similar to subtypes of non-Hodgkin’s lymphoma identified in people.
• Histopathological subtypes:
B cell- marginal zone (MZL), follicular lymphoma
(FL) and mantle cell lymphoma (MCL ),
T-zone lymphoma (TZL).
HISTOPATHOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
(Valli et al, 2010)
53. • B cell predominant
• Both B and T cell indolent lymphomas share a low mitotic rate,
slow rate of progression
• TZL can be difficult to recognize as malignancy given the small
mature –appearing cell type and low mitotic activity.
• Detection of clonality is useful adjunct to histologic
examination
HISTOPATHOLOGY:
CANINE LYMPHOMA- SPECIAL CONSIDERATIONS
INDOLENT LYMPHOMA
54. Clinical features
Histopathology
Immunohistochemistry
Clonality testing
Clinical follow up and
repeat biopsy
NAILING THE DIAGNOSIS: MAKING THE MOST OF OUR PATHOLOGY
Cytology
• Make sure what you are sampling is what you wish to sample
• Make sure what you have sampled is of diagnostic quality
• Make sure that you submit an adequate number of slides
• Diagnosis is inconclusive
• Diagnosis does not fit clinical picture
• Where a more precise diagnosis will influence prognosis ortreatment
•Round cell neoplasia
•Immunophenotyping
•Clonality testing
•Fibrohistiocytic splenic neoplasia
•Intestinal neoplasia (sarcoma, other)